Success: Password updated and now signed in
Success: Your password has been updated

Available to following accounts
Sponsored by

Biopharmaceuticals offer great hope in treating medical conditions which are currently poorly served at best by traditional pharmaceuticals. It is estimated that there are over 400 biopharmaceuticals in clinical trails for in excess of 200 disease areas. The enhanced complexity and variability that comes from the size of biopharmaceuticals, allied with the intricacy of the production process, mean chromatography is employed to a much greater extent during production and release testing. This webcast will provide details of why differing modes of chromatography are required in the research, preparation and analysis of biopharmaceuticals and when they would be typically used.


Topics include:

  • Introduction to biopharmaceuticals
  • Protein characteristics of analytical interest
  • Use of various HPLC techniques to analyze proteins at intact (native), fragmented, peptide, glycan and amino acid levels including;
    • Reversed phase (RPLC)
    • Size exclusion chromatography (SEC)
    • Ion exchange chromatography (IEX)
    • Hydrophilic interaction chromatography (HILIC)
    • Affinity chromatography
  • Advances in throughput, specificity and accuracy for peptide mapping, charged variant analysis, aggregation and titer analysis


Key learning objectives:

  • Understand the differences between traditional small molecule and larger biopharmaceuticals and their relative advantages
  • Review the complexity associated with producing and analyzing biopharmaceutical products
  • Identify the commonly employed LC techniques when working with biopharmaceuticals
  • Learn how and when each of the techniques are employed and associated benefits


Who should attend:

  • Anyone interested in analyzing biopharmaceuticals
  • Anyone working in analysis peptides, proteins or monoclonal antibodies
  • Anyone working with HPLC
  • Anyone who wishes to learn about different HPLC techniques


Presented by: 

Dr. Davy Guillarme (Senior Lecturer, University of Geneva, University of Lausanne)

Scott Fletcher (Technical Business Development Manager, Crawford Scientific)